Retatrutide is an investigational once-weekly injectable medication that activates three hormone receptors (GLP-1, GIP, and glucagon) to promote weight loss
They trigger GH release through a different cascade (phospholipase C, inositol triphosphate, calcium mobilization) while partially suppressing somatostatin
Always consult a licensed healthcare provider before beginning any medication, supplement, or weight loss program
Other lipotropic injection side effects include: Headaches and light headedness Stomach upsets such as mild nausea and mild diarrhea Allergic reactions (itching, hives, shortness of breath, wheezing, swelling of the tongue, throat, or mouth) although rare, can also occur
This could theoretically support tumor growth and vascularization